Le Lézard
Classified in: Health, Business
Subjects: SVY, LIC

Fragrance ingredient exposure is orders of magnitude below thresholds of concern, study shows


A paper published in Regulatory Toxicology and Pharmacology reveals consumer exposure to fragrance to be extremely low

MAHWAH, N.J., Feb. 6, 2024 /PRNewswire/ -- The Research Institute for Fragrance Materials, Inc. (RIFM), in collaboration with scientific modeling, data analytics, and computing company Creme Global, compared the fragrance exposure of the highest-end product users to the Threshold of Toxicological Concern (TTC) and Dermal Sensitization Threshold (DST) to determine a realistic understanding of consumer exposure to fragrance. The TTC is based on the U.S. Food and Drug Administration's Threshold of Regulation, which it expands upon to include consideration of an ingredient's molecular structure in conjunction with its toxicity data. The TTC approach is internationally recognized by regulators including the European Food Safety Authority (EFSA).

A paper published in Regulatory Toxicology and Pharmacology reveals consumer exposure to fragrance to be extremely low

The study authors compared exposure to the approximately 3,000 in-use fragrance-producing ingredients to their respective TTCs and DSTs. Representative fragrance ingredients were randomly selected and analyzed for exposure distribution by product type (i.e., personal, household, oral, and air care) and route of exposure. Exposure calculations were performed by the Creme-RIFM Aggregate Exposure model, which provides realistic exposure estimates that consider all fragrances the population is exposed to across all products used.

(Read the published paper https://doi.org/10.1016/j.yrtph.2024.105569.)

The study's lead author, Isabelle Lee, Ph.D., Senior Scientist of Dermatotoxicology at RIFM, explained, "We found that 76% of fragrance-producing ingredients fall below their TTC levels when compared to the systemic exposure experienced by the highest-end users, while 99% of fragrance ingredients are below inhalation exposure TTC levels."

Paper co-author Anne Marie Api, PhD, RIFM's president, explained, "It may seem there is a lot of an ingredient in a product because our nose tells us it's there. But our olfactory sense is far better than most realize. We can easily detect something at concentrations of parts per million and, in many cases, parts per billion. Thus, very little fragrance is required to impart a desired scent."

About RIFM

RIFM assesses the safety of fragrance ingredients by the most current, internationally accepted guidelines?and has done so since its founding in 1966. RIFM's peer-reviewed safety assessments and research are free to the public via fragrancematerialsafetyresource.elsevier.com.

Media Contact:

The Research Institute for Fragrance Materials, Inc. (RIFM)

Gary Sullivan

Marketing & Communications Manager

[email protected]

SOURCE Research Institute for Fragrance Materials (RIFM)


These press releases may also interest you

30 jun 2024
SCG Cell Therapy Pte Ltd (SCG), a biotechnology company developing novel immunotherapies for infectious diseases and their associated cancers, today announced that U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug...

30 jun 2024
"AI in healthcare is extremely challenging. For companies, it requires not only solving scientific problems but also understanding AI technology and respecting the complexity of the healthcare industry." At the 15th Annual Meeting of the New...

30 jun 2024
"AI in healthcare is extremely challenging. For companies, it requires not only solving scientific problems but also understanding AI technology and respecting the complexity of the healthcare industry." At the 15th Annual Meeting of the New...

30 jun 2024
On June 27, 2024, Yidu Tech Inc. (the ''Company'' or ''Yidu Tech'') (2158.HK), a leader in China's AI medical industry, announced its results for the 2024 fiscal year. During the reporting period, the Company recorded revenue of RMB 807.1 million....

30 jun 2024
Yidu Tech Inc. ("Yidu Tech" or the "Company", together with its subsidiaries and consolidated affiliated entities, the "Group", HKEX: 2158) announced its annual results for the fiscal year ended 31 March 2024 ("FY2024" or the "Reporting Period"). The...

30 jun 2024
CBC Group ("CBC"), Asia's largest healthcare-dedicated asset management firm headquartered in Singapore, announced that its controlled portfolio company, Hasten Biopharmaceutical ("Hasten"), an innovation-driven biopharmaceutical company, has...



News published on and distributed by: